Get the Stockscreener App
45.04
0.55%
-0.25
After Hours:
45.05
0.010
+0.02%
Medline Inc stock is traded at $45.04, with a volume of 2.22M.
It is down -0.55% in the last 24 hours and up +11.15% over the past month.
Medline Inc provides medical-surgical products and supply chain solutions for various healthcare settings. Its offerings include med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. It serves hospitals, surgery centers, physician offices, and post-acute care facilities, supporting patient care needs. The company operates in two segments: Medline Brand and Supply Chain Solutions. The company's revenues are generated principally from the sale of its surgical products.
See More
Previous Close:
$45.29
Open:
$45.34
24h Volume:
2.22M
Relative Volume:
0.78
Market Cap:
$37.48B
Revenue:
$27.43B
Net Income/Loss:
$1.27B
P/E Ratio:
28.45
EPS:
1.5829
Net Cash Flow:
$1.01B
1W Performance:
+0.16%
1M Performance:
+11.15%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$44.34
$45.73
1-Week Range:
$44.34
$47.99
52-Week Range:
$38.50
$47.99
Medline Inc Stock (MDLN) Company Profile
Name
Medline Inc
Sector
Industry
Phone
-
Address
-
Compare MDLN vs ISRG, BDX, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
45.04 | 37.69B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ISRG
Intuitive Surgical Inc
|
496.12 | 175.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
180.62 | 48.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.39 | 39.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.62 | 38.39B | 5.40B | 1.49B | 1.78B | 10.12 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-26 | Initiated | Tigress Financial | Buy |
| Jan-21-26 | Reiterated | BTIG Research | Buy |
| Jan-12-26 | Initiated | Citigroup | Buy |
| Jan-12-26 | Initiated | Deutsche Bank | Hold |
| Jan-12-26 | Initiated | Evercore ISI | Outperform |
| Jan-12-26 | Initiated | Goldman | Buy |
| Jan-12-26 | Initiated | JP Morgan | Overweight |
| Jan-12-26 | Initiated | Jefferies | Buy |
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-12-26 | Initiated | Mizuho | Outperform |
| Jan-12-26 | Initiated | Morgan Stanley | Overweight |
| Jan-12-26 | Initiated | Piper Sandler | Overweight |
| Jan-12-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-12-26 | Initiated | Robert W. Baird | Outperform |
| Jan-12-26 | Initiated | Rothschild & Co Redburn | Neutral |
| Jan-12-26 | Initiated | Stifel | Buy |
| Jan-12-26 | Initiated | TD Cowen | Buy |
| Jan-12-26 | Initiated | Truist | Buy |
| Jan-12-26 | Initiated | UBS | Buy |
| Jan-12-26 | Initiated | Wells Fargo | Equal Weight |
| Jan-12-26 | Initiated | William Blair | Outperform |
| Jan-12-26 | Initiated | Wolfe Research | Outperform |
View All
Medline Inc Stock (MDLN) Latest News
Is It Too Late To Consider Medline (MDLN) After Its Recent Share Price Rally? - Yahoo Finance
Medline stock pops 40% in first trading session after company raises $6.3 billion in 2025's biggest IPO - AOL.com
Evaluating Medline (MDLN) After Recent Share Price Momentum And A 31.1x P/E Multiple - Sahm
Medline Inc. (MDLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Medline Inc.Class A common stock (NQ: MDLN - FinancialContent
MDLN Medline Inc. Feb 2026 Tigress Financial Initiates Coverage with Buy - Meyka
Tigress Financial initiates Medline stock with Buy rating, $55 target By Investing.com - Investing.com Nigeria
Tigress Financial initiates Medline stock with Buy rating, $55 target - Investing.com
Jim Boyle: 100 Most Influential People in Healthcare 2025 - Modern Healthcare News
Medline (NASDAQ:MDLN) Now Covered by Analysts at Tigress Financial - MarketBeat
Tigress Initiates Medline at Buy With $55 Price Target - marketscreener.com
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio - The Motley Fool
Wash. Justices Won't Hear Medline's $2.4M Refund Request - Law360
Medline CEO Jim Boyle talks record IPO and AI plans with hospitals - Crain's Chicago Business
Medline’s Jim Boyle talks record IPO, AI plans with hospitals - Modern Healthcare News
Medline to report fourth quarter and full year 2025 results on February 25, 2026 - GlobeNewswire
Is It Time To Reassess Medline (MDLN) After Its Recent Share Price Climb - Yahoo Finance
Medline Inc (MDLN) Shares Up 3.65% on Jan 22 - GuruFocus
Jim Cramer says Medline stock is unbelievable and recommends buying it - MSN
Jim Cramer Says Medline "Stock Is Unbelievable" And Recommends Buying It - Finviz
Medline price target raised to $55 from $50 at BTIG - Yahoo Finance
Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway (NASDAQ:MDLN) - Seeking Alpha
Jim Cramer Recently Looked at These 25 Stocks - Insider Monkey
Is There An Opportunity In Medline (MDLN) After Recent DCF Valuation Results - Sahm
Pointcore Supply Chain Services members select Medline as distributor - Medline Newsroom
Ranpak expands packaging automation partnership with Medline - Packaging Insights
In face of uncertainty and tariffs, newly public Medline sticks to the old formula - Crain's Chicago Business
Ranpak and Medline deepen packaging automation collaboration - Yahoo Finance
Ranpak in Collaboration with Medline - Medical Device and Diagnostic industry
Medline Shares Climb as Analysts Launch Coverage After $7.2 Bill - GuruFocus
Medline Shares Climb as Analysts Launch Coverage After $7.2 Billion IPO - Yahoo Finance
Ranpak and Medline Partner to for High-Volume Distribution Operations From: Ranpak Corporation - Healthcare Packaging
Ranpak Holdings Corp. and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - marketscreener.com
Ranpak and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Medline, Inc. Class A (MDLN) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Medline jumps as analysts bullish after 2025’s top IPO - The Daily Gazette
Medline Jumps as Analysts Bullish After 2025’s Top IPO - Bloomberg
Analysts initiate coverage on Medline after IPO, flag growth visibility and margin - Investing.com
Why Is Medline Stock Gaining Monday?Medline (NASDAQ:MDLN) - Benzinga
Analysts Say Medline Has The Secret Sauce For Sustained Growth - Sahm
Is Medline (MDLN) Fairly Priced After Recent Share Price Stability? - Yahoo Finance
Analysts initiate Medline with bullish ratings after blockbuster IPO - Reuters
TD Cowen initiates Medline stock with Buy rating on market share growth - Investing.com Nigeria
BTIG initiates coverage on Medline stock with Buy rating, $50 target By Investing.com - Investing.com South Africa
Wells Fargo & Company Begins Coverage on Medline (NASDAQ:MDLN) - MarketBeat
This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Medline initiated with a Buy at BTIG - TipRanks
Goldman Sachs Initiates Coverage on Medline With Buy Rating, $49 Price Target - marketscreener.com
BMO Capital Initiates Coverage on Medline With Outperform Rating, $45 Price Target - marketscreener.com
JPMorgan Initiates Coverage on Medline With Overweight Rating, $50 Price Target - marketscreener.com
Medline Inc Stock (MDLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
5.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):